IL17A and obesity due to melanocortin 4 receptor deficiency: Previous studies have shown that IL-17 can delay the progression of obesity, suggesting that the findings of Jung et al. may be due to decreased IL-17 leading to a weakened inhibitory effect on adipogenesis and adipocyte differentiation, which leads to obesity in adolescents; this proposal supports the above mentioned effects of IL-17.